Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion type Assertion NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_head.
- NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion description "[In addition, cervical squamous cell carcinoma and adenocarcinoma have distinct molecular profiles, suggesting that clinical outcomes may be improved with the use of more tailored treatment strategies, including PI3K and MEK inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_provenance.
- NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion evidence source_evidence_literature NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_provenance.
- NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion SIO_000772 24037752 NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_provenance.
- NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion wasDerivedFrom befree-20150227 NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_provenance.
- NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_assertion wasGeneratedBy ECO_0000203 NP624605.RALPM54cpp-fqG68APPfHVT4Ambux7qa9SRaMVdWlVEuU130_provenance.